sample of publications

• articles 

  • Regenerative Cosmetics: Skin Tissue Engineering for Anti-Aging, Repair, and Hair Restoration.  Cosmetics.  11 (4). 2024
  • Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa.  BRITISH JOURNAL OF DERMATOLOGY.  189:774-776. 2023
  • Multi-omic data integration in food science and analysis.  Current Opinion in Food Science.  52. 2023
  • Untargeted metabolomic study by liquid chromatography&-mass spectrometry in brain tissues on the effects of combined cocaine and ethanol self-administration in male and female young rats.  JOURNAL OF CHROMATOGRAPHY A.  1700. 2023
  • Untargeted metabolomic analysis to explore the impact of soil amendments in a non-conventional wastewater treatment.  Science of The Total Environment.  870. 2023
  • Metabolic fingerprinting of chemotherapy-resistant prostate cancer stem cells. An untargeted metabolomic approach by liquid chromatography mass spectrometry.  Frontiers in Cell and Developmental Biology.  10:01-16. 2022
  • Mechanistic interrogation of mutation-independent disease modulators of RDEB identifies the small leucine-rich proteoglycan PRELP as a TGF-beta antagonist and inhibitor of fibrosis.  MATRIX BIOLOGY.  111:189-206. 2022
  • Molecular characterization of the response to haploidentical mesenchymal stem cells treatment in recessive dystrophic epidermolysis bullosa patients.  JOURNAL OF INVESTIGATIVE DERMATOLOGY.  141:S176-S176. 2021
  • DNA Repair and Immune Response Pathways Are Deregulated in Melanocyte-Keratinocyte Co-cultures Derived From the Healthy Skin of Familial Melanoma Patients.  Frontiers in Medicine.  8:1-8. 2021
  • Drug repurposing using biological networks.  Processes.  9:1-14. 2021
  • Transcriptomic Analysis of a Diabetic Skin-Humanized Mouse Model Dissects Molecular Pathways Underlying the Delayed Wound Healing Response.  Genes.  12 (1):1-13. 2020
  • Impact of Extreme Obesity and Diet-Induced Weight Loss on the Fecal Metabolome and Gut Microbiota.  MOLECULAR NUTRITION & FOOD RESEARCH.  65:1-9. 2020
  • Foodomics evaluation of the anti-proliferative potential of Passiflora mollissima seeds.  FOOD RESEARCH INTERNATIONAL.  130. 2020
  • Anti-proliferative bioactivity against HT-29 colon cancer cells of a withanolides-rich extract from golden berry (Physalis peruviana L.) calyx investigated by Foodomics.  Journal of Functional Foods.  63. 2019
  • Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer-prone genodermatoses.  BRITISH JOURNAL OF DERMATOLOGY.  181:512-522. 2019
  • Oxidative stress imbalance as contributing factor in the establishment of fibrosis in recessive dystrophic epidermolysis bullosa.  JOURNAL OF INVESTIGATIVE DERMATOLOGY.  139:S631-S631. 2019
  • Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR/Cas9-Mediated Gene Editing.  MOLECULAR THERAPY.  27:986-998. 2019
  • Foodomics evaluation of bioactive compounds in foods.  TRAC-TRENDS IN ANALYTICAL CHEMISTRY.  96:2-13. 2017
  • 116 Comparative transcriptomic analysis of fibroblasts from two sisters with discordant severe generalized recessive dystrophic epidermolysis bullosa phenotype reveals new molecular markers associated with disease severity.  JOURNAL OF INVESTIGATIVE DERMATOLOGY.  137:S212-S212. 2017
  • 601 Common mechanisms and signaling pathways in fibroblasts of cancer-prone genodermatoses.  JOURNAL OF INVESTIGATIVE DERMATOLOGY.  137:S295-S295. 2017
  • Urinary Metabolomic Profiling Reveals the Effect of Shenfu Decoction on Chronic Heart Failure in Rats.  MOLECULES.  20:11915-11929. 2015

• conference contributions 

  • Systemic metabolomics in recessive dystrophic epidermolysis bullosa paediatric patients to determine therapeutic mechanisms of mesenchymal stem cells.  13-13. 2021
  • Clinically-relevant correction of recessive dystrophic epidermolysis bullosa by dual sgRNA CRISPR/Cas9-mediated gene editing.  A116-A117. 2018
  • Disease Severity Modulators in Recessive Dystrophic Epidermolysis Bullosa.  31-32. 2018